These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 17883551)
1. Evidence review and ENT-UK consensus report for the use of aminoglycoside-containing ear drops in the presence of an open middle ear. Phillips JS; Yung MW; Burton MJ; Swan IR Clin Otolaryngol; 2007 Oct; 32(5):330-6. PubMed ID: 17883551 [TBL] [Abstract][Full Text] [Related]
2. Ototoxic ear drops with grommet and tympanic membrane perforations: a position statement. Black RJ; Cousins VC; Chapman P; Becvarovski Z; Coates HL; O'Leary SJ; Perry CF; Williams BJ Med J Aust; 2007 Jun; 186(11):605-6. PubMed ID: 17547553 [No Abstract] [Full Text] [Related]
3. Summary of the findings of a joint consensus panel on the use of potentially ototoxic ototopicals. Roland PS; Ear Nose Throat J; 2004 Sep; 83(9 Suppl 4):13-4. PubMed ID: 15543836 [No Abstract] [Full Text] [Related]
4. Animal ototoxicity of topical antibiotics and the relevance to clinical treatment of human subjects. Roland PS; Rybak L; Hannley M; Matz G; Stewart MG; Manolidis S; Friedman R; Weber P; Owens F Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S57-78. PubMed ID: 15054364 [TBL] [Abstract][Full Text] [Related]
5. Ototoxicity of ototopical drops--an update. Haynes DS; Rutka J; Hawke M; Roland PS Otolaryngol Clin North Am; 2007 Jun; 40(3):669-83, xi. PubMed ID: 17544701 [TBL] [Abstract][Full Text] [Related]
6. Ototoxic eardrops and tympanic membrane perforations: time for a change? Coates H J Paediatr Child Health; 2005 Aug; 41(8):401-4. PubMed ID: 16101971 [TBL] [Abstract][Full Text] [Related]
7. Vestibular Hypofunction Secondary to Topical Use of Aminoglycosides in Ears with Perforated Tympanic Membrane. González-Aguado R; Veiga-Alonso A; Morales-Angulo C Audiol Neurootol; 2024; 29(5):425-428. PubMed ID: 38588647 [TBL] [Abstract][Full Text] [Related]
8. Topical antibiotic ototoxicity: does it influence our practice? Ho EC; Alaani A; Irving R J Laryngol Otol; 2007 Apr; 121(4):333-7. PubMed ID: 17134534 [TBL] [Abstract][Full Text] [Related]
9. Re: Guidelines for use of aminoglycoside-containing ear drops. Giddings CE; Rimmer J Clin Otolaryngol; 2008 Apr; 33(2):164. PubMed ID: 18429892 [No Abstract] [Full Text] [Related]
12. Survey on the use of ototopical medications by New Zealand otolaryngologist/head and neck surgeons. Mahadevan M; Wabnitz DA; McIntosh DL; Brown CR N Z Med J; 2008 Jan; 121(1268):U2898. PubMed ID: 18256713 [TBL] [Abstract][Full Text] [Related]
13. Topical aminoglycosides in the management of active mucosal chronic suppurative otitis media. Lancaster JL; Makura ZG; Porter G; McCormick M J Laryngol Otol; 1999 Jan; 113(1):10-2. PubMed ID: 10341911 [TBL] [Abstract][Full Text] [Related]
18. Benefits of aminoglycoside drops still outweigh the risks. Haynes DS Ear Nose Throat J; 2003 Jan; 82 Suppl 1():16. PubMed ID: 12610890 [No Abstract] [Full Text] [Related]
19. Aminoglycoside ear drop ototoxicity: a topical dilemma? Walby P; Stewart R; Kerr AG Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):289-90. PubMed ID: 9762488 [No Abstract] [Full Text] [Related]
20. Ototoxicity of Topical Antibiotic Ear Drops in Chronic Suppurative Otitis Media in Humans: A Review of the Literature. Hussain SZM; Hashmi SS; Qayyum A Cureus; 2022 Dec; 14(12):e32780. PubMed ID: 36686080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]